...
首页> 外文期刊>Journal of pharmacological sciences. >Effects of selective estrogen receptor modulators on plasma membrane estrogen receptors and catecholamine synthesis and secretion in cultured bovine adrenal medullary cells
【24h】

Effects of selective estrogen receptor modulators on plasma membrane estrogen receptors and catecholamine synthesis and secretion in cultured bovine adrenal medullary cells

机译:选择性雌激素受体调节剂对牛肾上腺髓质细胞质膜雌激素受体和儿茶酚胺合成与分泌的影响

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We previously reported the occurrence and function of plasma membrane estrogen receptors in cultured bovine adrenal medullary cells. Here we report the effects of raloxifene and tamoxifen, selective estrogen receptor modulators, on plasma membrane estrogen receptors and catecholamine synthesis and secretion in these cells. Raloxifene caused dual effects on the specific binding of [3H]17b-estradiol to the plasma membranes isolated from bovine adrenal medulla; that is, it had a stimulatory effect at 1.0 - 10 nM but an inhibitory effect at 1.0 - 10 mM, whereas tamoxifen (1.0 nM - 10 mM) increased binding at all concentrations (except for 100 nM). Tamoxifen at 100 nM caused a significant increase in basal 14C-catecholamine synthesis from [ 14C]tyrosine, whereas tamoxifen and raloxifene at higher concentrations attenuated basal and acetylcholine-induced 14C- catecholamine synthesis. Raloxifene (0.3, 1.0, and 3 - 100 mM) and tamoxifen (10 - 100 mM) also suppressed catecholamine secretion and 45Ca 2+ and 22Na+ influx, respectively, induced by acetylcholine. Raloxifene (1.0 mM) inhibited Na+ current evoked by acetylcholine in Xenopus oocytes expressing a4b2 neuronal nicotinic acetylcholine receptors. The present findings suggest that raloxifene and tamoxifen at low concentrations allosterically modulate plasma membrane estrogen receptors and at high concentrations inhibit acetylcholine-induced catecholamine synthesis and secretion by inhibiting Na+ and Ca 2+ influx in bovine adrenal medulla.
机译:我们先前报道了培养的牛肾上腺髓质细胞中质膜雌激素受体的发生和功能。在这里,我们报告了雷洛昔芬和他莫昔芬(选择性雌激素受体调节剂)对这些细胞质膜雌激素受体以及儿茶酚胺合成和分泌的影响。雷洛昔芬对[3H] 17b-雌二醇与从牛肾上腺髓质分离的质膜的特异性结合产生双重影响。也就是说,它在1.0-10 nM时有刺激作用,而在1.0-10 mM时有抑制作用,而他莫昔芬(1.0 nM-10 mM)在所有浓度下(100 nM除外)都增加结合。 100 nM的他莫昔芬从[14C]酪氨酸引起基础14C-儿茶酚胺的合成显着增加,而他莫昔芬和雷洛昔芬在更高的浓度下会减弱基础和乙酰胆碱诱导的14C-儿茶酚胺的合成。雷洛昔芬(0.3、1.0和3-100 mM)和他莫昔芬(10-100 mM)也分别抑制了乙酰胆碱引起的儿茶酚胺分泌以及45Ca 2+和22Na +流入。雷洛昔芬(1.0 mM)抑制表达a4b2神经元烟碱型乙酰胆碱受体的爪蟾卵母细胞中乙酰胆碱引起的Na +电流。目前的发现表明,低浓度的雷洛昔芬和他莫昔芬能通过抑制牛肾上腺髓质中的Na +和Ca 2+流入而变构地调节质膜雌激素受体,而高浓度抑制乙酰胆碱诱导的儿茶酚胺的合成和分泌。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号